GLYTR

GlyTR is an early-stage biotech company developing an entirely new class of immunotherapeutic anti-cancer molecules and cells... GlyTR is a platform technology that generates both bi-specific proteins and chimeric antigen receptor T cells (CAR T).

Also known as: GlyTR Therapeutics

Primary location: Irvine United States